Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
Canadian clearance supports site activation and enrollment in the global study of once-daily oral PALI-2108Primary efficacy results from approximately 204 patients with moderately to severely active ulcerative colitis expected in the second half of 2027Denver, CO, Sept. 23, 2026 (GLOBE NEWSWIRE…